Correlation between Tumor Regression and T Cell Responses in Melanoma Patients Vaccinated with a MAG...
Correlation between Tumor Regression and T Cell Responses in Melanoma Patients Vaccinated with a MAGE Antigen
About this item
Full title
Author / Creator
Publisher
United States: National Academy of Sciences
Journal title
Language
English
Formats
Publication information
Publisher
United States: National Academy of Sciences
Subjects
More information
Scope and Contents
Contents
The cancer-germline gene MAGE-3 codes for tumor-specific antigens recognized on many tumors by T lymphocytes. A MAGE-3 antigen presented by HLA-A1 has been used in several vaccination trials on metastatic melanoma patients. Only a small minority of patients have shown evidence of tumor regression. Attempts to correlate the tumor rejections with the...
Alternative Titles
Full title
Correlation between Tumor Regression and T Cell Responses in Melanoma Patients Vaccinated with a MAGE Antigen
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pnas_primary_101_suppl_2_14631
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pnas_primary_101_suppl_2_14631
Other Identifiers
ISSN
0027-8424
E-ISSN
1091-6490
DOI
10.1073/pnas.0405743101
